Advancing the Role of BTK Inhibitors in B-Cell Malignancies: Expert Guidance to Refine Clinical Management Strategies

Activity

Progress
1
Course Completed
Activity Information

Physicians: Maximum of 2.75 AMA PRA Category 1 Credits

Released: February 04, 2020

Expiration: February 03, 2021